Procela Consulting was Founded in 2003.
Procela Consulting Global Public Health stands for transparent inclusive socially responsible consulting in the management of pharmaceutical resources to benefit those who do not have necessary medical treatments in low and middle income countries. Procela Consulting has been advising and consulting in the interest of Global Public Health since 2003. Some of Procela's achievements include:
Advising major pharmaceutical multinational companies on the establishment of Global Access to Medicines Programs in developing countries. The management and strategic guidance of start-up biotech and medical devices companies, including raising over $500m in venture capital funding and concluding over 20 technology transfer licenses with industry and academia.
Long-standing projects with the foremost pharmaceutical companies to develop access in Low and Middle income countries. along with periodic reporting to Agencies and Foundations on critical aspects of HIV/AIDS treatment in developing countries, -most recently:
2014 -2016
Procela has worked closely with Indian generic pharmaceutical manufacturers of antiretroviral drugs to advocate with Global Fund and Pepfar to modify their procurement processes.
Procela Completed a Major report for UNIDO, UNAIDS and WHO on the security of supply of HIV/Aids commodities. Procela Completed a review of the AUC/UNIDO Pharmaceutical Manufacturing Plan for Africa for WHO.
Procela completed project advising Strategies for implementation of the Pharmaceutical Manufacturing Plan for Africa for WHO/UNIDO.
Brian Elliott Procela's CEO addressed the special UN Assembly meeting on the security of supply of antiretroviral medication in lower and middle income countries.
Ongoing
Advising Governments in sub – Saharan Africa, - particularly Uganda, Tanzania, Lesotho, Ghana, Rwanda in the establishment of projects to improve domestic access to medicines.
Recent work has is focused on establishing a major project to improve the quality of medicines in the East African market.
Publications
"Antiretrovirals for low income countries: an analysis of the commercial viability of a highly competitive market, Authors: Nakakeeto N Olive, Elliott V Brian, Globalization and Health, Feb 2013"